OVID THERAPEUTICS INC (OVID) 1.74 -0.01 (-0.57%)
1.74 -0.01 (-0.57%)
US6904691010 - Common Stock - After market: 1.65 -0.09 (-5.17%)
Buy % Consensus
Analysts have set a mean price target of 5.61. This target is 222.41% above the current price.
OVID was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about OVID.
In the previous month the buy percentage consensus was at a similar level.
OVID was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-20 | Citigroup | Maintains | Neutral |
| 2021-08-25 | Citigroup | Maintains | Neutral |
| 2021-04-20 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA